KEYTRUDA 25 mg/mL concentrate for solution for infusion
CTRIAL-IE 16-12
Phase 3 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion for High risk resected melanoma. is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- High risk resected melanoma.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active